Clinical Trials Directory

Trials / Sponsors / AGO Research GmbH

AGO Research GmbH

Industry · 8 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingPembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulv
Recurrent Vulvar Cancer, Persistent Vulvar Cancer, Metastatic Vulva Cancer
Phase 22025-06-24
WithdrawnStudy to Estimate Efficacy of Combining Dostarlimab and Niraparib in Relapsed EOC After Treatment With PARPi
Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Primary Peritoneal Cancer
Phase 22023-11-01
RecruitingWoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC
Epithelial Ovarian Cancer
Phase 22022-05-05
Active Not RecruitingMirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
Phase 22021-10-13
TerminatedEvaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer
Recurrent Ovarian Carcinoma
Phase 32019-08-09
CompletedAtezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer
Recurrent Ovarian Carcinoma
Phase 32018-09-11
CompletedPrevalence of BRCA in Patients With Ovarian Cancer
BRCA Status, Ovarian Cancer
—2015-03-01
CompletedEvaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer
Recurrent Platinum-sensitive Ovarian Cancer
Phase 32013-05-01